Novel methods to assess the effectiveness of chemotherapy in AML patients: MRD
Understanding why CLL patients stop responding to treatment, and options for salvage therapies
Where are we with precision medicine for CLL?
Enhancing immunotherapy for CLL patients with ibrutinib
The use of CLL-IPI, a new prognostic index for CLL